Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia

Phase 1 Unknown 40 enrolled South China Research Center for Stem Cell and Regenerative Medicine

RandomizedParallel-groupOpen-labelTreatment

Summary

The intent of this clinical study is to evaluate the safety of the injection composed of autologous bone marrow derived endothelial cells (BM-ECs) and platelet-rich plasma extract (PRPE) for the treatment of critical limb ischemia.

Timeline

Start: 2018-03
Primary completion: 2019-12
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	BM-ECs	Cell therapy	—	Intramuscular
Subject	platelet-rich plasma extract	Unknown	—	Intramuscular

Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia

Summary

Timeline

Drugs

Indications